PBMs' rebate income threatened by lawsuits and move to generics.
作者信息
Sipkoff Martin
出版信息
Manag Care. 2008 Mar;17(3):11-2.
PMID:18447152
Abstract
摘要
相似文献
1
PBMs' rebate income threatened by lawsuits and move to generics.
Manag Care. 2008 Mar;17(3):11-2.
2
Four-dollar generics--increased accessibility, impaired quality assurance.四美元的非专利药——可及性提高，质量保证受损。
N Engl J Med. 2010 Nov 11;363(20):1885-7. doi: 10.1056/NEJMp1006189.
3
Could a Wal-Mart PBM succeed?沃尔玛的药品福利管理公司能成功吗？
Manag Care. 2008 Apr;17(4):36-8.
4
Employers want plans & PBMs to push hard for generics.雇主希望保险公司和药品福利管理公司大力推广仿制药。
Manag Care. 2007 Jan;16(1):15-6.
5
Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.品牌药与仿制药之间的竞争——品牌药定价分析
Health Econ. 2009 May;18(5):591-606. doi: 10.1002/hec.1392.
6
Recently introduced generics helped PBM control its costs.
Manag Care. 2005 Nov;14(11):77.
7
When success sours: PBMs under scrutiny.当成功变味：药品福利管理公司受到审视。
Manag Care. 2002 Sep;11(9):20-6.
8
The impact of generic substitution on price competition in Finland.仿制药替代对芬兰价格竞争的影响。
Eur J Health Econ. 2008 May;9(2):185-91. doi: 10.1007/s10198-007-0059-0. Epub 2007 May 17.
9
Competition and the Reference Pricing Scheme for pharmaceuticals.药品竞争与参考定价机制。
J Health Econ. 2011 Dec;30(6):1137-49. doi: 10.1016/j.jhealeco.2011.08.010. Epub 2011 Sep 3.
10
Generic drugs get a life.仿制药获得了新生。
Mark Health Serv. 2003 Spring;23(1):18-23.
Zotero 插件